Issue 4 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

24

No.

4

April 27, 2001Apr 27, 2001

Free

DOWNLOAD THE PDF

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I

Wilms’ Tumor Survivors At High Risk Of Heart Failure

Cancer Pain Treatment Guide Published By NCCN, ACS

Without Advance Directives, Families Prolong Treatment

Long-Term Estrogen Use May Increase Ovarian Cancer Risk

Natural Substance Blocks Androgen Activity In Vitro

NCI-Approved Clinical Trials Listed For Month Of March

Recent Issues

Volume 52 | Issue 16 - April 24, 2026

Volume 52 | Issue 15 - April 17, 2026

Volume 52 | Issue 14 - April 10, 2026

Volume 52 | Issue 13 - April 03, 2026

Volume 52 | Issue 12 - March 27, 2026

Volume 52 | Issue 11 - March 20, 2026